Please login to the form below

Not currently logged in
Email:
Password:

Ofev

This page shows the latest Ofev news and features for those working in and with pharma, biotech and healthcare.

Boehringer posts solid first half as business revamp beds in

Boehringer posts solid first half as business revamp beds in

Boehringer’s pharma division also benefited from a gain for Ofev (nintedanib), its drug for idiopathic pulmonary fibrosis (IPF), which grew almost 22% to 677m in the first half.

Latest news

More from news
Approximately 7 fully matching, plus 13 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics